Axogen (AXGN) logo

Axogen (AXGN) stock

Nerve repair products , market cap $3.0B

$51.63
+4.29%

As of 10:43 AM ET, delayed 15+ min · Live for Pro members

Quality Score
16
Excellent
In its industry
#6of 85

AXGN's Quality Score rose 1 point on Wed, Nov 4, to 16.

See AXGN's 14 chart checksSee it live, free for 24 hours. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Why is AXGN up?

Up 4.3% today with medical device stocks: Neuronetics rose 23.5% after its report; 80 of 85 are up, 5.9% on average; the S&P 500 is up 1.6%; energy and AI power stocks fell.

Rose on Oct 28

Up 31.5% on Oct 28, and still 32% over its Oct 27 close.

  • Its Oct 28 results: revenue was $75.8M, from $60.1M a year before; net income was $2.3M, from $0.7M. It rose 32% on Oct 28.

Sources: Price history, Oct 28, 2026; Company release, Oct 28, 2026

1 more reason, free with an account →1 more reason why AXGN rose on Oct 28, from its filings, with the other side, the timeline, and its peers, for Pro members.

Key facts on AXGN

Key facts on AXGN
The companySales up 63% $138.6M → $225.2M in 3 years
Latest filing8-K, Oct 28 Reported its quarterly results
1 more reason behind AXGN's 16, free with an account →4 more reasons behind AXGN's 16, for Pro members.

AXGN in the news

TodayWith its group.

What's next

Wed Nov 11: Canaccord Genuity 20th Annual…Investor conference · date confirmed.

2 more dates ahead: conferences, for Pro members.

AXGN catalysts

Coming up

After its last 4 reports it closed +7.6% on average, higher 3 of 4 times.

16 past catalysts since 2018, with sizes and sources, for Pro members.Get in free →

Why AXGN scores 16

Excellentfor quality, not price, 8 of 14 chart checks firingWhat the Quality Score means

Well above its recent run. AXGN scores 16 today, against a median of 4 over its last 20 recorded sessions.

  • +8Chart checks 8 of 14 firing right now, one point each
  • +4Long-term trend above a rising 200-⁠day average, near its 52-⁠week high, at a multi-⁠year high
  • Run-up adds
  • Profit subtractsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
  • Growth addsSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.
  • Dilution subtractsNew shares over the year: -1 at 10% more, -2 at 25% more.
  • News adds

No effect today: Size, Volatility, Cash flow, and Persistence.

What every line is worth, and the reason behind it, on AXGN and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 10:43 AM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Alert me when AXGN's Quality Score turns up

See it live, free for 24 hours. No account. No card. Then keep going with a free account.

Here is what Pro members see.

  • The same page for Pro members, on AMD

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on AXGN and every other stock.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

AXGN has 8 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on AXGN, and all 14 on every stock.Get in free →

AXGN RSI today: 76.2, above its 50-day and 200-day averages

Not scored

Not in the Quality Score: over 20 years of tests, 2006 to 2026, they added no edge.

The deep dive on AXGN

9 more findings on AXGN, each with its source, for Pro membersGet in free →

How AXGN ranks in Medical Devices

AXGN is #6 of 85 by Quality Score.

How AXGN ranks in Medical Devices
6Axogen (AXGN) logoAXGNAxogen16

More in Medical Devices

When does AXGN report earnings, and what happens after?

Expected to report Tue Feb 23, before the open (in 111 days). Expected.

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What AXGN reported on Oct 28, 2026

The quarter

Sales of $75.8M, 26% more than a year ago; a profit of $0.04 a share, from $0.01.

The quarter that ended Sep 30, from the company's press release

The press releaseThe filing on EDGAR

Where the sales came from

AXGN's results filing gives no sales by line in a table we read.

The outlook

The outlook the company gave, by period
MeasureFigure
Full year 2026
Full-year revenueat least $290 millionraised

Figures as filed (SEC filing, Oct 28)

4 more outlook lines, for Pro members.

The numbers

Market value
$3B
today
Sales
$251M
up 23.6% on the year
Free cash flow
$8.6M
last 12 months

Sales grew 15% a year over 5 years, fiscal 2020 to 2025.

Its share count grew 2.9% a year over 5 years.

5 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on AXGN: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.Get in free →
ReportedGapReaction5
sessions
Oct 28, 2026Before open+21.3%+31.5%+32.1%
Jul 29, 2026Before open-6.9%+0.5%+11.7%
Apr 28, 2026Before open+9.2%+6.6%+8.2%

AXGN closed higher after 3 of its last 4 reports.

All 4 reports, and AXGN's Quality Score going into each

AXGN sales and profit by year

Sales and profit by year

Sales grew every year from 2018 to 2025, to $225M. It lost money in each of the eight years.

AXGN share count over time

Shares: 15.8% more than a year ago (to Jun 30).

Shares of AXGN outstanding, as filed
Shares
outstanding
As
of
53.8MJul 27, 2026
53.2MApr 24, 2026
51.9MFeb 20, 2026
46.1MOct 27, 2025
Offerings, shelves, and splits of AXGN, from its filings
From its
filings
Filed
Raised $208.7M in a sale of shares, about 7% of its market valueSep 10, 2026
Priced a sale of sharesJan 23, 2026

Insiders trading AXGN

AXGN insider trades

One insider sold $70K across 1 filing in the last 6 months. No open-⁠market buys on record. The newest:

SellAmy McBride Wendell$70KDirectorat $42.60 on May 8, filed May 12

AXGN's officers and directors

Officers and directors with a Form 4 in the last 12 months.

5 more officers and directors file at AXGN. Each page above names the rest.

See insider trades by person

Which ETFs hold AXGN?

In ETFs: AXGN is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About Axogen

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

622 employeesAlachua, FLaxogeninc.com

What Axogen says it competes with

“The medical device and biotechnology industries are characterized by rapidly advancing technologies, intense competition, and a strong emphasis on proprietary products.”

From its annual report, SEC filing · Feb 24, 2026

2 more sentences, what it says it does, and its sales by region, for Pro membersGet in free →

AXGN's score card

Axogen (AXGN): Quality Score 16, Excellent, #6 of 85 in Medical Devices, with its price, on Breakaway
The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

  • What would move AXGN's score: 5 things
  • 5 more filings explained, a plain line each
  • Real-⁠time prices, no delay
BreakawayMay 12Amy McBride Wendell sold AXGN$70K at $42.60, filed May 12

Alerts are optional.

See AXGN's 14 chart checks

See it live, free for 24 hours. No account. No card. Then keep going with a free account.

Straight Answers

As of Nov 4, 2026: AXGN's Quality Score is 16 (Excellent), #6 of 85 in Medical Devices. Insiders sold $70K in the last 6 months (Form 4).

Is AXGN a good stock to buy? What its Quality Score says

AXGN scores 16 today, which Breakaway calls Excellent. It is #6 of 85 in Medical Devices by Quality Score, with 8 of 14 chart checks firing. Up 31.5% on Oct 28, and still 32% over its Oct 27 close. Shares: 15.8% more than a year ago (to Jun 30). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is AXGN's Quality Score?

AXGN scores 16 today, which Breakaway calls Excellent (15 to 19). That is #6 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind AXGN's 16.

Are insiders buying AXGN?

One insider sold $70K across 1 filing in the last 6 months. No open-⁠market buys on record. The newest is Amy McBride Wendell, Director, who sold $70K on May 8.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.